secwatch.observer — SEC 8-K summary
======================================

Issuer:     Turn Therapeutics Inc. (TTRX)
CIK:        0002023016
Form:       8-K
Filed at:   2026-05-19T12:15:30+00:00
Accession:  0001213900-26-058730
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Turn Therapeutics CEO to present at Jefferies Global Healthcare Conference June 4
--------------------------------------------------------------------------------

- Bradley Burnam, CEO, to present at Jefferies Global Healthcare Conference in New York City on June 4, 2026.
- Presentation scheduled from 9:55 AM to 10:25 AM EDT.
- Live webcast accessible via Turn Therapeutics investor relations website; replay available for ~6 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2023016/000121390026058730/0001213900-26-058730-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2023016/000121390026058730/ea0291410-8k_turn.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-058730

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer